Oxcarbazepine Serum Test

Monitoring serum concentration during oxcarbazepine therapy, Assessing compliance, Assessing potential toxicity

Test is recommended for patients being treated with Oxcarbazepine for seizures

In clinical practice, the OCBZ dosage should be individually adjusted for each patient to achieve the desired therapeutic response. Toxicity associated with OCBZ includes hyponatremia, dizziness, somnolence, diplopia, fatigue, nausea, vomiting, ataxia, abnormal vision, abdominal pain, tremor, dyspepsia, and abnormal gait. Hence Therapeutic monitoring of Oxcarbazepine and its active metabolite are important for achieving proper serum/plasma concentration to inhibit epileptic seizures and avoid adverse effects.